Emergency medicine (EM) teams must be prepared to care for patients experiencing adverse events of cancer therapies, which is no small task. In this on-demand video, an expert EM physician and multiple myeloma (MM) specialist will provide an in-depth review of the latest novel therapy for MM — bispecific antibodies (bsAbs). EM care teams will learn the basics of this unique therapy, including the prompt identification and effective co-managing of potential adverse events associated with bsAb therapies.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/frontline-emergency-medicines-role-managing-bispecific-antibody-events
- Start Date: 2024-08-21 05:00:00
- End Date: 2024-08-21 05:00:00
- Credit Details: IPCE Credits: 0.25 hours
AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Janssen (Any division) - Amount: 12500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest